The Series D funds targeted alpha therapy for solid tumors using AI-powered isotope targeting.
A deep learning model predicts aggressive liver cancer from CT scans across 3,100 patients, potentially replacing biopsies for treatment selection.
Owkin and AstraZeneca are expanding their AI collaboration to develop new drug discovery models using federated learning, a technique that…